Search results
Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and a leading player in the domestic branded formulation market. Ranked # 21 in the IPM, Eris has established a leading presence in its core cardio-metabolic franchise in just 17 years from inception.
Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and a leading player in the domestic branded formulations market. Ranked # 21 in the IPM, Eris has established a leading presence in its core cardio-metabolic franchise in just 17 years from inception.
Eris Lifesciences Pvt Ltd is fastest growing super speciality focused pharmaceutical company and is engaged in manufacturing, marketing and selling of branded generics across the country.
Product Name Molecule Form Moleculee Strength Therapy; Advog 0.2: Each uncoated tablet contains: Voglibose IP 0.2 mg: Tablet: VOGLIBOSE: 0.2 MG: ANTI DIABETIC: Advog 0.3
Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and is a leading player in the domestic branded formulations market. Ranked #21 in the IPM, Eris has established a...
Mar 14, 2024 · Eris Lifesciences Ltd acquires Biocon Biologics' Branded Formulations business for Rs 1,242 crore ($169 million). Acquisition makes Eris a leader in India's Rs 30,000 crore ($4 billion)...
5 days ago · Eris Lifesciences Limited Stock Price Today, Live NSE Share Price: Get the latest Eris Lifesciences Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
